OBJECTIVE: Wolfram syndrome is a rare form of diabetes mellitus associated with optic atrophy and disorders of different organs (e.g. diabetes insipidus, hearing loss, ataxia, anaemia and many others). This syndrome is caused by recessive mutations in the wolframin gene (WFS1) localized on chromosome 4p16·1. The aim of this study was to identify the causative mutations in WFS1 in a group of Polish patients with suspected Wolfram syndrome. PATIENTS AND MEASUREMENTS: Nine patients with clinical symptoms consistent with Wolfram syndrome (at least diabetes mellitus and optic atrophy) and 22 first-degree relatives were examined. The molecular analysis was carried out by direct sequencing of the exons, the exon-intron junctions, and the 5' and 3' untranslated regions of WFS1. RESULTS: Nine different mutations in WFS1 (five of them novel) were identified in the nine patients. Six patients were homozygous for the following mutations: V412fs, S443R, W539X, V659fs. They developed diabetes at a mean age of 5·2 years. Three patients were compound-heterozygous for the following mutations: S167fs, Q392X, Y513fs, W648X, V779G. They developed diabetes at a mean age of 6·5 years. CONCLUSIONS: Mean age of diagnosis of diabetes among the Polish patients was typical for Wolfram syndrome; however, compound-heterozygous patients were slightly older at diabetes onset.
OBJECTIVE:Wolfram syndrome is a rare form of diabetes mellitus associated with optic atrophy and disorders of different organs (e.g. diabetes insipidus, hearing loss, ataxia, anaemia and many others). This syndrome is caused by recessive mutations in the wolframin gene (WFS1) localized on chromosome 4p16·1. The aim of this study was to identify the causative mutations in WFS1 in a group of Polish patients with suspected Wolfram syndrome. PATIENTS AND MEASUREMENTS: Nine patients with clinical symptoms consistent with Wolfram syndrome (at least diabetes mellitus and optic atrophy) and 22 first-degree relatives were examined. The molecular analysis was carried out by direct sequencing of the exons, the exon-intron junctions, and the 5' and 3' untranslated regions of WFS1. RESULTS: Nine different mutations in WFS1 (five of them novel) were identified in the nine patients. Six patients were homozygous for the following mutations: V412fs, S443R, W539X, V659fs. They developed diabetes at a mean age of 5·2 years. Three patients were compound-heterozygous for the following mutations: S167fs, Q392X, Y513fs, W648X, V779G. They developed diabetes at a mean age of 6·5 years. CONCLUSIONS: Mean age of diagnosis of diabetes among the Polish patients was typical for Wolfram syndrome; however, compound-heterozygous patients were slightly older at diabetes onset.
Authors: Agnieszka Zmyslowska; Bogdan Malkowski; Wojciech Fendler; Maciej Borowiec; Karolina Antosik; Piotr Gnys; Dobromila Baranska; Wojciech Mlynarski Journal: PLoS One Date: 2014-12-26 Impact factor: 3.240
Authors: Maciej Borowiec; Wojciech Młynarski; Agnieszka Zmyslowska; Marcin Stanczak; Zuzanna Nowicka; Arleta Waszczykowska; Dobromila Baranska; Wojciech Fendler Journal: BMJ Open Diabetes Res Care Date: 2020-11
Authors: Alberto La Valle; Gianluca Piccolo; Mohamad Maghnie; Giuseppe d'Annunzio Journal: Int J Environ Res Public Health Date: 2021-11-15 Impact factor: 3.390
Authors: Wojciech Mlynarski; Wojciech Fendler; Agnieszka Zmyslowska; Miljan Kuljanin; Beata Malachowska; Marcin Stanczak; Dominika Michalek; Aneta Wlodarczyk; Dagmara Grot; Joanna Taha; Bartłomiej Pawlik; Magdalena Lebiedzińska-Arciszewska; Hanna Nieznanska; Mariusz R Wieckowski; Piotr Rieske; Joseph D Mancias; Maciej Borowiec Journal: Cell Commun Signal Date: 2021-11-20 Impact factor: 5.712
Authors: A Zmyslowska; W Fendler; A Szadkowska; M Borowiec; M Mysliwiec; A Baranowska-Jazwiecka; M Buraczewska; M Fulmanska-Anders; B Mianowska; I Pietrzak; D Rzeznik; W Mlynarski Journal: Acta Diabetol Date: 2015-04-29 Impact factor: 4.280
Authors: Agnieszka Zmyslowska; Wojciech Fendler; Arleta Waszczykowska; Anna Niwald; Maciej Borowiec; Piotr Jurowski; Wojciech Mlynarski Journal: Acta Diabetol Date: 2017-08-30 Impact factor: 4.280